Drug Trial Radar · NCT07318597
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
99
Planned (sponsor's estimate)
Start
May 6, 2026
Primary completion
Feb 27, 2028
Study completion Sep 17, 2028
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- First posted
- Jan 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching an experimental drug called REGN13335. The study is focused on participants with Pulmonary Arterial Hypertension (PAH). The aim of the study is to see how safe and effective REGN13335 is in participants with PAH who are taking other PAH medicines. The study is looking at several other research questions, including: * What side effects may happen from taking REGN13335 * How much REGN13335 is in the blood at different times * Whether the body makes antibodies against REGN13335 (which could make REGN13335 less effective or could lead to side effects)
Conditions
- Pulmonary Arterial Hypertension (PAH)
Interventions
REGN13335Drug
Administered per the protocol
PlaceboDrug
Administered per the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Pulmonary Vascular Resistance (PVR)Time frame: At week 24
Locations
33 sites in 10 countries. Site status is shown where the registry gives one.
University of Colorado Denver
Aurora, Colorado · Recruiting
Tufts Medical Center
Boston, Massachusetts · Recruiting
University of Nebraska Medical Center - 2365
Omaha, Nebraska · Recruiting
University of Cincinnati
Cincinnati, Ohio · Recruiting
The Prince Charles Hospital
Brisbane, Queensland, Australia · Recruiting
Mater Misericordiae Ltd
South Brisbane, Queensland, Australia · Recruiting
Royal Hobart Hospital
Hobart, Tasmania, Australia · Recruiting
H.U.B. Erasme Hospital
Brussels, Belgium · Recruiting
UZ Leuven
Leuven, Vlaams-Brabant, Belgium · Recruiting
Hopital Bicetre
Le Kremlin-Bicêtre, France · Recruiting
Nouvel hopital civil
Strasbourg, France · Recruiting
Clinic of University Greifswald
Greifswald, Germany · Recruiting
Universitatsmedizin Mainz
Mainz, Germany · Recruiting
Universitatsklinikum Halle
Halle, Saxony-Anhalt, Germany · Recruiting
P. Stradins Clinical University hospital
Riga, Latvia · Recruiting
Gornoslaskie Centrum Medyczne, Prof. Leszek Giec, Sląski Uniwersytet Medyczny, Katowice
Katowice, Poland · Recruiting
University Clinical Hospital in Poznan - Early Phase Unit
Poznan, Greater Poland Voivodeship, Poland · Recruiting
Oddzial Kardiologiczny
Lodz, Łódź Voivodeship, Poland · Recruiting
University Hospital in Bialystok
Bialystok, Podlaskie Voivodeship, Poland · Recruiting
Seoul National University Hospital
Seoul, South Korea · Recruiting
Severance Hospital
Seoul, South Korea · Recruiting
Samsung Medical Center
Seoul, South Korea · Recruiting
Gachon University Gil Medical Center
Namdong-gu, Incheon, South Korea · Recruiting
Asan Medical Center
Seoul, Songpa-gu, South Korea · Recruiting
Hospital Clinic, Barcelona
Barcelona, Spain · Recruiting
University hospital 12 de octubre
Madrid, Spain · Recruiting
University Hospital Salamanca
Salamanca, Spain · Recruiting
Hospital Universitario De Toledo
Toledo, Spain · Recruiting
Hospital Vall d'Hebron
Barcelona, Catalonia, Spain · Recruiting
Hospital Universitario Costa del Sol
Marbella, Malaga, Spain · Recruiting
Royal United Hospitals Bath NHS Foundation Trust
Bath, United Kingdom · Recruiting
Royal Free Hospital
London, United Kingdom · Recruiting
Imperial College Healthcare NHS Trust, Hammersmith Hospital
London, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.